NH SPAC 2 (206640) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.043x

Based on the latest financial reports, NH SPAC 2 (206640) has a cash flow conversion efficiency ratio of 0.043x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.46 Billion ≈ $7.09 Million USD) by net assets (₩244.18 Billion ≈ $165.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of NH SPAC 2 to measure how many days the company can operate on defensive assets alone.

NH SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how NH SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NH SPAC 2 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NH SPAC 2 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
KHVATEC Co.Ltd
KQ:060720
0.116x
Trabzonspor Sportif Yatirim ve Futbol Isletmeciligi Ticaret AS
IS:TSPOR
0.651x
Samjin Pharm
KO:005500
-0.005x
SPML Infra Limited
NSE:SPMLINFRA
-0.023x
Southern Petrochemicals Industries Corporation Limited
NSE:SPIC
0.592x
Daios Plastics S.A.
AT:DAIOS
N/A
POLARIS RENEWABLE ENERGY
F:N4T
N/A
Gordon Auto Body Parts Co Ltd
TW:1524
0.088x

Annual Cash Flow Conversion Efficiency for NH SPAC 2 (2015–2025)

The table below shows the annual cash flow conversion efficiency of NH SPAC 2 from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of NH SPAC 2.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩244.18 Billion
≈ $165.48 Million
₩22.08 Billion
≈ $14.96 Million
0.090x -18.92%
2024-12-31 ₩223.05 Billion
≈ $151.16 Million
₩24.88 Billion
≈ $16.86 Million
0.112x -35.80%
2023-12-31 ₩197.42 Billion
≈ $133.79 Million
₩34.30 Billion
≈ $23.24 Million
0.174x +23.18%
2022-12-31 ₩163.56 Billion
≈ $110.84 Million
₩23.07 Billion
≈ $15.63 Million
0.141x -57.32%
2021-12-31 ₩151.09 Billion
≈ $102.39 Million
₩49.93 Billion
≈ $33.83 Million
0.330x -11.28%
2020-12-31 ₩119.86 Billion
≈ $81.23 Million
₩44.64 Billion
≈ $30.25 Million
0.372x +58.88%
2019-12-31 ₩73.55 Billion
≈ $49.84 Million
₩17.24 Billion
≈ $11.68 Million
0.234x +188.18%
2018-12-31 ₩65.33 Billion
≈ $44.27 Million
₩5.31 Billion
≈ $3.60 Million
0.081x +522.67%
2017-12-31 ₩67.87 Billion
≈ $46.00 Million
₩886.74 Million
≈ $600.93K
0.013x -91.67%
2016-12-31 ₩75.17 Billion
≈ $50.94 Million
₩11.79 Billion
≈ $7.99 Million
0.157x -3.10%
2015-12-31 ₩59.50 Billion
≈ $40.32 Million
₩9.63 Billion
≈ $6.53 Million
0.162x --

About NH SPAC 2

KQ:206640 Korea Medical Devices
Market Cap
$156.06 Million
₩230.28 Billion KRW
Market Cap Rank
#17587 Global
#734 in Korea
Share Price
₩10740.00
Change (1 day)
-1.92%
52-Week Range
₩10120.00 - ₩15090.00
All Time High
₩36222.75
About

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testi… Read more